Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

NCT00575068 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen